These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6299906

  • 1. An assessment of sequential measurements of immune complex levels in ovarian cancer patients with respect to clinical progress.
    Mooney NA, Townsend PA, Wiltshaw E, Evans DG, Shanti-Raju K, Poulton TA.
    Gynecol Oncol; 1983 Apr; 15(2):207-13. PubMed ID: 6299906
    [Abstract] [Full Text] [Related]

  • 2. Natural killer cell activity and progression-free survival in ovarian cancer.
    Garzetti GG, Cignitti M, Ciavattini A, Fabris N, Romanini C.
    Gynecol Obstet Invest; 1993 Apr; 35(2):118-20. PubMed ID: 8383627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy of ovarian cancer. New approaches to treatment.
    Smith JP, Rutledge F, Wharton JT.
    Cancer; 1972 Dec; 30(6):1565-71. PubMed ID: 4345098
    [No Abstract] [Full Text] [Related]

  • 5. Ovarian carcinoma; second-look laparotomy postchemotherapy. Preliminary report.
    Webster KD, Ballard LA.
    Cleve Clin Q; 1981 Dec; 48(4):365-71. PubMed ID: 6276049
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenic heterogeneity in human ovarian cancer.
    Welch WR, Niloff JM, Anderson D, Battaile A, Emery S, Knapp RC, Bast RC.
    Gynecol Oncol; 1990 Jul; 38(1):12-6. PubMed ID: 2162315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors influencing ovarian cancer survival after chemotherapy.
    Webb MJ, Malkasian GD, Jorgensen EO.
    Obstet Gynecol; 1974 Oct; 44(4):564-70. PubMed ID: 4413425
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer.
    Dodd J, Davey RA, McAdam A, Stimson WH, Fay R, Crandon AJ, Hicks L, Tyler JP, Hudson CN.
    Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):203-5. PubMed ID: 3101659
    [Abstract] [Full Text] [Related]

  • 12. [Analysis of results of monochemotherapy of ovarian cancer with special reference to long-term survival].
    Sablińska B, Cześnin K, Ploch E.
    Nowotwory; 1984 Aug; 34(3):229-35. PubMed ID: 6099543
    [No Abstract] [Full Text] [Related]

  • 13. Ethics of chemotherapy during pregnancy.
    Fancher KM, Giannetti V, McLaughlin BT.
    Am J Health Syst Pharm; 2019 Feb 01; 76(4):242-246. PubMed ID: 30715184
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy in the treatment of cancer of the ovary.
    Smith JP, Rutledge F.
    Am J Obstet Gynecol; 1970 Jul 01; 107(5):691-703. PubMed ID: 4316665
    [No Abstract] [Full Text] [Related]

  • 16. [Methods of optimizing and objective criteria for evaluating the efficacy of chemo-surgical treatment of malignant epithelial tumors of the ovaries].
    Nechaeva ID, Vinokurov VL, Iurkova LE, Kotova DG, Aĭnbinder NM, Livshits MA, Zel'dovich DR, Mitrokhina MV.
    Vopr Onkol; 1990 Jul 01; 36(8):992-5. PubMed ID: 2171227
    [Abstract] [Full Text] [Related]

  • 17. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
    Maughan TS, Fish RG, Shelley M, Jasani B, Williams GT, Adams M.
    Gynecol Oncol; 1988 Jul 01; 30(3):342-6. PubMed ID: 2839394
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures.
    Tentes AA, Mirelis CG, Markakidis SK, Bekiaridou KA, Bougioukas IG, Xanthoulis AI, Tsalkidou EG, Zafiropoulos GH, Nikas IH.
    Int J Gynecol Cancer; 2006 Jul 01; 16(2):490-5. PubMed ID: 16681716
    [Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H, Terao T, Kawashima Y.
    J Clin Oncol; 1991 Jun 01; 9(6):983-7. PubMed ID: 1851822
    [Abstract] [Full Text] [Related]

  • 20. Human monoclonal antibody recognizing an antigen associated with ovarian and other adenocarcinomas.
    Smith LH, Yin A, Glasky MS, Tyler N, Robles M, Foster CA, Bieber M, Teng NN.
    Am J Obstet Gynecol; 1992 Feb 01; 166(2):634-45. PubMed ID: 1371375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.